 tools, intraoperative imaging or robotic systems, and improved endovascular grafts that facilitate repair in the presence of
challenging anatomy and improve the safety and accuracy of device deployment; and (6) to identify approaches that reliably treat type I and type II
endoleaksdall within the framework of enhancing
cost-effective care.
A number of areas of uncertainty also exist in the care of
patients with an AAA in the application of existing technology that would beneÔ¨Åt from further investigation